Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SILDENAFIL 10 MG/ML ORAL SUSP

Sildenafil Citrate
$0.3840per ML

Strength

10 mg/mL

Manufacturer

Zydus Pharmaceuticals (USA) Inc.

NDC

70710171604

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

SILDENAFIL CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215708

On Market Since

10/27/2022

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price History

1W

0.0%

1M

-8.7%

3M

-17.5%

6M

-37.1%

1Y

-43.9%

3Y

N/A

5Y

N/A

All

-51.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SILDENAFIL 20 MG TABLET
Generic
00904667104•Major Pharmaceuticals
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
00904667106•Major Pharmaceuticals
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
13668018590•Torrent Pharmaceuticals Limited
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
27241012403•Ajanta Pharma USA Inc.
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
27241012405•Ajanta Pharma USA Inc.
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
31722077605•Camber Pharmaceuticals Inc.
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
31722077690•Camber Pharmaceuticals Inc.
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
33342012110•Macleods Pharmaceuticals Limited
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
33342053610•Macleods Pharmaceuticals Limited
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
50268071715•AvPAK
$0.0514
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy